Published in Eur J Nucl Med Mol Imaging on January 20, 2007
Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases. Eur J Nucl Med Mol Imaging (2007) 1.61
Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride. Eur J Nucl Med Mol Imaging (2015) 0.83
Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry. Cancer Biother Radiopharm (2015) 0.75
Skeletal complications of malignancy. Cancer (1997) 5.41
Complication probability as assessed from dose-volume histograms. Radiat Res Suppl (1985) 3.85
Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys (1989) 3.77
Samarium-153-EDTMP biodistribution and dosimetry estimation. J Nucl Med (1993) 3.65
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. Lancet (2001) 2.85
Accurate condensed history Monte Carlo simulation of electron transport. I. EGSnrc, the new EGS4 version. Med Phys (2000) 2.71
Therapy of metastatic bone pain. J Nucl Med (2001) 1.94
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol (1998) 1.92
Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial. J Nucl Med (2002) 1.73
A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases. J Clin Oncol (1989) 1.73
Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial. J Nucl Med (1993) 1.55
Short- and long-term effects of 186Re-1,1-hydroxyethylidene diphosphonate in the treatment of painful bone metastases. J Nucl Med (2000) 1.47
Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer. J Nucl Med (1989) 1.47
A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer (1991) 1.44
Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases. J Nucl Med (1994) 1.37
Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. Br J Radiol (1991) 1.21
A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer (1997) 1.20
Bone-seeking radionuclides for therapy. J Nucl Med (2005) 1.12
Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: results of a randomized controlled trial. Semin Oncol (1993) 1.11
Pain in far-advanced cancer. Pain (1982) 1.09
NMR microscopy of trabecular bone and its role in skeletal dosimetry. Health Phys (1998) 1.08
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases. Bone (2006) 1.02
Re-186(Sn) HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies. Radiology (1988) 1.01
Dosimetry and toxicity of Quadramet for bone marrow ablation in multiple myeloma and other haematological malignancies. Eur J Nucl Med Mol Imaging (2002) 0.99
Samarium-153 EDTMP therapy of disseminated skeletal metastasis. Eur J Nucl Med (1989) 0.92
S values for radionuclides localized within the skeleton. J Nucl Med (2000) 0.90
Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients. Breast Cancer Res Treat (2001) 0.86
Calculated beta-ray dose factors for trabecular bone. Phys Med Biol (1976) 0.85
Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease. J Nucl Med (2001) 0.84
Strontium-89 therapy: measurement of absorbed dose to skeletal metastases. J Nucl Med (1988) 0.83
Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer. Eur J Nucl Med (1997) 0.83
Dose response relationship and multiple dose efficacy and toxicity of samarium-153-EDTMP in metastatic cancer to bone. Radiother Oncol (1997) 0.81
Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma. J Nucl Med (1992) 0.79
Measurements of the microscopic structure of cortical bone. Phys Med Biol (1977) 0.79
A three-dimensional transport model for determining absorbed fractions of energy for electrons within trabecular bone. J Nucl Med (1999) 0.78
Radionuclide therapy with bone seeking radionuclides in palliation of painful bone metastases. J Exp Clin Cancer Res (2003) 0.76
A Monte Carlo simulation model for radiation dose to metastatic skeletal tumor from rhenium-186(Sn)-HEDP. J Nucl Med (1995) 0.76
Platinum compounds as radiosensitizers in strontium-89 metabolic radiotherapy. Clin Ter (1998) 0.75
Samarium-153-EDTMP bone uptake rate and its relation to therapeutic effect. Chin Med J (Engl) (2002) 0.75
Cancer-related pain and its pharmacologic management in the patient with bone metastasis. J Support Oncol (2006) 0.75
A three-dimensional transport model for determining absorbed fractions of energy for electrons within cortical bone. J Nucl Med (1999) 0.75
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma. Ann Oncol (2005) 1.49
Short- and long-term effects of 186Re-1,1-hydroxyethylidene diphosphonate in the treatment of painful bone metastases. J Nucl Med (2000) 1.47
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer (2010) 1.39
The cryopreserved stented pulmonary homograft valve in the tricuspid position. J Card Surg (1991) 1.39
CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection. Clin Exp Immunol (1996) 1.35
Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. J Periodontal Res (1996) 1.31
Comparison of conformal radiation therapy techniques within the dynamic radiotherapy project 'Dynarad'. Phys Med Biol (2000) 1.27
Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients. Spinal Cord (2002) 1.26
Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol (2009) 1.25
The effect of systemically administered PDGF-BB on the rodent skeleton. J Bone Miner Res (1996) 1.15
Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas. J Clin Oncol (1998) 1.06
Cell kinetics and growth of squamous cell carcinomas in man. Cancer Res (1974) 1.03
Different underlying neurocognitive deficits in developmental dyslexia: a comparative study. Neuropsychologia (2009) 1.00
Genome-wide analysis of Italian sheep diversity reveals a strong geographic pattern and cryptic relationships between breeds. Anim Genet (2013) 0.99
Experimental determination of calibration settings of a commercially available radionuclide calibrator for various clinical measurement geometries and radionuclides. Appl Radiat Isot (2006) 0.99
Serum levels of RANTES and MIP-1 alpha in HIV-positive long-term survivors and progressor patients. AIDS (1996) 0.99
Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects. J Clin Invest (1997) 0.97
Neurological and functional outcome in traumatic central cord syndrome. Spinal Cord (2006) 0.97
Electromagnetic interference by GSM cellular phones and UHF radios with intensive-care and operating-room ventilators. Biomed Instrum Technol (2001) 0.96
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen. Pharmacogenomics J (2012) 0.95
S-100 and NSE as serum markers in melanoma. Acta Oncol (1997) 0.94
The responsiveness of bone metastases to radiotherapy: the effect of site, histology and radiation dose on pain relief. Radiother Oncol (1989) 0.93
Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice. Cancer Res (1999) 0.93
Crossed cerebello-cerebral diaschisis: a SPECT study. Nucl Med Commun (1992) 0.93
Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimen. Leukemia (2003) 0.92
In vitro and in vivo potentiation by lonidamine of the antitumor effect of adriamycin. Anticancer Res (1987) 0.92
Seizures in paediatric Chiari type I malformation: the role of single-photon emission computed tomography. Acta Paediatr (2002) 0.91
Unilateral oculomotor nerve palsy: unusual sign of hydrocephalus. J Neurosurg Sci (2009) 0.90
Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma. J Nucl Med (1997) 0.90
Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89. Nucl Med Commun (1996) 0.90
Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2. Clin Exp Immunol (1999) 0.89
[The role of autoimmune mechanisms in the hyperthyroidism-viral hepatitis syndrome: a possible noncausal association. A review of the literature and the authors' own cases]. Minerva Med (1990) 0.87
Single fraction partial breast irradiation in prone position. J Exp Clin Cancer Res (2007) 0.86
Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients. Breast Cancer Res Treat (2001) 0.86
Ascending myelopathy in the early stage of spinal cord injury. Spinal Cord (1999) 0.85
Genetic diversity in Egyptian and Italian goat breeds measured with microsatellite polymorphism. J Anim Breed Genet (2008) 0.85
Characterization of single nucleotide polymorphisms in sheep and their variation as evidence of selection. Anim Genet (2006) 0.84
99Tcm-MIBI scintimammography in 300 consecutive patients: factors that may affect accuracy. Nucl Med Commun (1999) 0.84
Comparison of dose distributions in IMRT planning using the gamma function. J Exp Clin Cancer Res (2006) 0.84
Spinal cord injuries due to diving accidents. Spinal Cord (2005) 0.83
Clinical relevance of radionuclide angiography and antimyosin immunoscintigraphy for risk assessment in epirubicin cardiotoxicity. J Nucl Cardiol (1998) 0.83
99mTc-MIBI scintimammography using a dedicated nuclear mammograph. J Nucl Med (1999) 0.83
Targeted "bone-seeking" radiopharmaceuticals for palliative treatment of bone metastases: a systematic review and meta-analysis. Q J Nucl Med Mol Imaging (2012) 0.83
Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy. Ann Oncol (2003) 0.82
Comparison of detecting sensitivities of different sizes of gold particles with electron-microscopic immunogold staining using atrial natriuretic peptide in rat atria as a model. Am J Anat (1989) 0.82
Comparison of IMRT planning with two-step and one-step optimization: a strategy for improving therapeutic gain and reducing the integral dose. Phys Med Biol (2009) 0.82
Somatostatin receptor imaging in CNS tumours using 111In-octreotide. Nucl Med Commun (1995) 0.82
Dosimetry in nuclear medicine therapy: radiobiology application and results. Q J Nucl Med Mol Imaging (2011) 0.82
Serum levels of intercellular adhesion molecule 1 in patients with HIV-related Kaposi's sarcoma. J Acquir Immune Defic Syndr (1994) 0.81
Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moon. Ann Oncol (2005) 0.81
Dynamics of provirus load and lymphocyte subsets after interleukin 2 treatment in HIV-infected patients. AIDS Res Hum Retroviruses (1999) 0.81
Atrial natriuretic peptide and its messenger ribonucleic acid in overloaded and overload-released ventricles of rat. Endocrinology (1989) 0.81
A heterogeneous dose distribution in simultaneous integrated boost: the role of the clonogenic cell density on the tumor control probability. Phys Med Biol (2008) 0.81
Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy. Scand J Infect Dis (2011) 0.80
Effects of aging on mucociliary clearance. Compr Gerontol A (1989) 0.80
Cytotoxic effect of the association of BCNU with rhein or lonidamine on a human glioma cell line. Anticancer Res (1991) 0.80
Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma. Clin Nucl Med (1996) 0.80
Establishment, characterization and chemosensitivity of two human glioma derived cell lines. J Neurooncol (1988) 0.80
Radiotherapy and hyperthermia. Analysis of clinical results and identification of prognostic variables. Cancer (1987) 0.80
Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade. J Clin Endocrinol Metab (1989) 0.80
Kinetics of lymphokine production in HIV+ patients treated with highly active antiretroviral therapy and interleukin 2. J Clin Immunol (1999) 0.80
Radioiodine-induced changes in lymphocyte subsets in patients with differentiated thyroid carcinoma. Eur J Nucl Med (1999) 0.80
Role of the parameters involved in the plan optimization based on the generalized equivalent uniform dose and radiobiological implications. Phys Med Biol (2008) 0.80
Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man. J Clin Endocrinol Metab (1990) 0.80
Different rates of CD4+ and CD8+ T-cell proliferation in interleukin-2-treated human immunodeficiency virus-positive subjects. Cytometry (2001) 0.79
One versus four heat treatments in combination with radiotherapy in metastatic mammary carcinoma. Int J Radiat Oncol Biol Phys (1991) 0.79
The breast dynamic contrast enhanced MRI: preliminary results of a quantitative analysis. J Exp Clin Cancer Res (2007) 0.79
Evaluation of metabolic status in amiodarone-induced thyroid disorders: plasma coenzyme Q10 determination. J Endocrinol Invest (1989) 0.79
CD8+ cells in HIV infection produce macrophage inflammatory protein-1 alpha and RANTES: a comparative study in long-term survivors and progressor patients. Immunol Lett (1996) 0.79
Clinical relevance of 111In-octreotide scans in CNS tumors. Q J Nucl Med (1995) 0.79
Spontaneous remission in adult patients with de novo myelodysplastic syndrome: a possible event. Haematologica (2001) 0.78
Acute spinal trauma: prognostic value of MRI appearances at 0.5 T. Clin Radiol (1993) 0.78
Tissue-specific downregulation of the adiponectin "system": possible implications for fat accumulation tendency in the pig. Domest Anim Endocrinol (2012) 0.78
Influence of time interval between surgery and radiotherapy on tumor regrowth. J Exp Clin Cancer Res (2005) 0.78
Ictal single photon emission computed tomography in absence seizures: apparent implication of different neuronal mechanisms. J Child Neurol (2001) 0.78
A radiopharmaceutical for the study of the liver: 99mTc-DTPA-asialo-orosomucoid. II: Human dynamic and imaging studies. J Nucl Med Allied Sci (1988) 0.78
Preliminary experience of a predictive model to define rectal volume and rectal dose during the treatment of prostate cancer. Br J Radiol (2011) 0.78
The effects of antineoplastic chemotherapy on HIV disease. AIDS Res Hum Retroviruses (1996) 0.78
Non-invasive radioisotopic evaluation of placental blood flow. Gynecol Obstet Invest (1985) 0.78
Interaction of cytotoxic agents: a rule-based system for computer-assisted cell survival analysis. Anticancer Res (1992) 0.78
Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo. Br J Cancer (1996) 0.78
Polymorphism of the goat agouti signaling protein gene and its relationship with coat color in Italian and Spanish breeds. Biochem Genet (2011) 0.78
Thermosensitization, heat shock protein synthesis and development of thermotolerance in M-14 human tumor cells subjected to step-down heating. Radiat Environ Biophys (1992) 0.77